SILK vs. NSPR

Last updated Apr 2, 2026

Compare and contrast key facts about Silk Road Medical, Inc (SILK) and InspireMD, Inc. (NSPR).

Performance

SILK vs. NSPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Silk Road Medical, Inc (SILK) and InspireMD, Inc. (NSPR). The values are adjusted to include any dividend payments, if applicable.

SILK vs. NSPR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
SILK Silk Road Medical, Inc	0.00%	0.00%	124.04%	-76.78%	24.03%	-32.34%	55.97%	11.61%
NSPR InspireMD, Inc.	-11.80%	-32.32%	-6.41%	226.93%	-71.54%	-40.94%	-68.44%	-73.66%

Fundamentals

Total Revenue (TTM) SILK : $191.43M NSPR : $8.98M
Gross Profit (TTM) SILK : $142.19M NSPR : $2.65M
EBITDA (TTM) SILK : -$45.89M NSPR : -$48.96M

Returns By Period

SILK

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NSPR

• 1D: -3.68%
• 1M: -14.21%
• YTD: -11.80%
• 6M: -34.58%
• 1Y: -38.07%
• 3Y*: 11.59%
• 5Y*: -31.02%
• 10Y*: -70.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SILK vs. NSPR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NSPR

NSPR Risk / Return Rank: 10
NSPR Sharpe Ratio Rank: 13
NSPR Sortino Ratio Rank: 14
NSPR Omega Ratio Rank: 15
NSPR Calmar Ratio Rank: 4
NSPR Martin Ratio Rank: 5

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SILK vs. NSPR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Silk Road Medical, Inc (SILK) and InspireMD, Inc. (NSPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	SILK	NSPR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.66	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.42	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.62	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.56	—

Correlation

The correlation between SILK and NSPR is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SILK vs. NSPR - Dividend Comparison

Neither SILK nor NSPR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	SILK	NSPR	Difference
Max Drawdown Largest peak-to-trough decline	—	-100.00%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-43.73%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-91.94%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-100.00%	—
Current Drawdown Current decline from peak	—	-100.00%	—
Average Drawdown Average peak-to-trough decline	—	-89.62%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	24.78%	—

Volatility

Volatility by Period

	SILK	NSPR	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	17.41%	—
Volatility (6M) Calculated over the trailing 6-month period	—	43.64%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	58.43%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	74.28%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	113.58%	—

Financials